VBI Vaccines files for bankruptcy
The Ontario Superior Court of Justice has issued an initial order granting protection, approving a debtor-in-possession loan from K2 HealthVentures LLC, and appointing Ernst & Young Inc. as monitor
VBI intends to seek approval for a sale and investment solicitation process (SISP) to identify potential buyers for its assets. The company plans to file for Chapter 15 bankruptcy in the U.S. and similar protection in Israel to safeguard its subsidiaries and assets in those countries. VBI expects its shares to cease trading on Nasdaq and to discontinue public reporting
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
